New disease-modifying antirheumatic drug 2 acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (KE-298) selectively augments activation-induced T cell death.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples